We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
Courtney Moc, PharmD, MS
Advertisement
Articles by Courtney Moc, PharmD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Vaccine for Lassa Fever Succeeds in First-in-Human Trial
2
Review of Cefepime and Zidebactam: A Novel Antibiotic Approved to Treat Complicated Urinary Tract Infections
3
FDA Expands Merck Pneumococcal Vaccine Indication to Include At-Risk Children and Adolescents
4
FDA Approves Tebipenem Pivoxil as First Oral Carbapenem For Complicated Urinary Tract Infections
5